Post-traumatic thrombotic microangiopathy: What trauma surgeons need to know?

• 作者: Hossain Mohammad A. Ahmed Nasim Gupta Varsha Bajwa Ravneet Alidoost Marjan Asif Arif Vachharajani Tushar
• 来源期刊: 中华创伤杂志英文版
• 关键词: Trauma Microangiopathy Complement amplifying condition
• 年，卷（期）: 2021,（2）
• 所属期刊栏目: Review Article
• 页码范围: 69-74
• 页数: 6页
• 语种: 中文
• DOI: 10.1016/j.cjtee.2021.01.004

摘要

Thrombotic microangiopathy (TMA) is characterized by systemic microvascular thrombosis, target organ injury, anemia and thrombocytopenia. Thrombotic thrombocytopenic purpura, atypical hemolytic uremic syndrome and Shiga toxin E-coli-related hemolytic uremic syndrome are the three common forms of TMAs. Traditionally, TMA is encountered during pregnancy/postpartum period, malignant hypertension, systemic infections, malignancies, autoimmune disorders, etc. Recently, the patients presenting with trauma have been reported to suffer from TMA. TMA carries a high morbidity and mortality, and demands a prompt recognition and early intervention to limit the target organ injury. Because trauma surgeons are the first line of defense for patients presenting with trauma, the prompt recognition of TMA for these experts is critically important. Early treatment of post-traumatic TMA can help improve the patient outcomes, if the diagnosis is made early. The treatment of TMA is also different from acute blood loss anemia namely in that plasmapheresis is recommended rather than platelet transfusion. This article familiarizes trauma surgeons with TMA encountered in the context of trauma. Besides, it provides a simplified approach to establishing the diagnosis of TMA. Because trauma patients can require multiple transfusions, the development of disseminated intravascular coagulation must be considered. Therefore, the article also provides different features of disseminated intravascular coagulation and TMA. Finally, the article suggests practical points that can be readily applied to the management of these patients.